XML 57 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Share-Based Compensation Expense

The table below sets forth the line items where share-based compensation expense was recorded for the twelve months ended December 31:

 

 

2024

 

 

2023

 

 

2022

 

Cost of goods sold

 

$

2,073

 

 

$

1,860

 

 

$

1,630

 

Selling, general and administrative expense

 

 

15,690

 

 

 

24,470

 

 

 

30,295

 

Research and development expense

 

 

5,004

 

 

 

4,581

 

 

 

4,362

 

Total share-based compensation expense

 

$

22,767

 

 

$

30,911

 

 

$

36,287

 

Schedule of Share-Based Compensation Expense by Type

The table below sets forth share-based compensation expense by type for the twelve months ended December 31:

 

 

2024

 

 

2023

 

 

2022

 

Share grants

 

 

22,767

 

 

 

30,894

 

 

 

36,251

 

Stock options

 

 

-

 

 

 

17

 

 

 

36

 

Total share-based compensation expense

 

$

22,767

 

 

$

30,911

 

 

$

36,287

 

Summary of Nonvested Share Grants

The table below sets forth a summary of our non-vested share grants in 2024, 2023, and 2022:

Restricted Stock Grants

 

Shares

 

 

Weighted Average Grant Date Fair Value ($)

 

 

Aggregate Intrinsic Value

 

Nonvested at December 31, 2022

 

 

1,269

 

 

 

65.29

 

 

$

96,634

 

Granted

 

 

645

 

 

 

84.87

 

 

 

 

Vested

 

 

(643

)

 

 

54.20

 

 

$

59,701

 

Forfeited and other

 

 

(48

)

 

 

73.33

 

 

 

 

Nonvested at December 31, 2023

 

 

1,223

 

 

 

81.02

 

 

$

98,493

 

Granted

 

 

517

 

 

 

70.96

 

 

 

 

Vested

 

 

(535

)

 

 

74.66

 

 

$

37,078

 

Forfeited and other

 

 

(57

)

 

 

80.22

 

 

 

 

Nonvested at December 31, 2024

 

 

1,148

 

 

 

79.56

 

 

$

70,824